Here's why 11,000 bottles of ear infection medication have been recalled nationwide
What to know about the problem.
Stay updated with breaking news from Degradation Specifications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
What to know about the problem.
Alembic Pharmaceuticals and Aurobindo Pharma are recalling products in the US due to manufacturing problems. Alembic is recalling 82,400 bottles of Tobramycin Ophthalmic Solution due to “Failed Impurities/Degradation Specifications.” Meanwhile, Aurobindo Pharma is recalling 48 bottles of Rufinamide Tablets, in both 200 mg and 400 mg doses, due to cGMP (current good manufacturing practice) deviations, USFDA said. The batch was released prior to approval. Rufinamide tablets are used to treat seizure disorders.
Biotechnology major Biocon is recalling 3,665 bottles of antifungal medication in the US market for "failed degradation specifications", according to the US Food and Drug Administration (USFDA).
USFDA noted that the New Jersey-based Biocon Pharma Inc is recalling the affected lot due to ‘Failed Impurities/Degradation Specifications: High Out Of Specification degradation results’.